<DOC>
	<DOCNO>NCT02073734</DOCNO>
	<brief_summary>The investigator hypothesize preoperative administration 8 mg IV dexamethasone benefit patient ' perceive quality recovery surgery .</brief_summary>
	<brief_title>Effects Preoperative Dexamethasone Study QOL After Vaginal Reconstructive Surgery POP</brief_title>
	<detailed_description>This randomize controlled trial involve single administration 8 mg Dexamethasone per IV preoperatively among woman undergo vaginal reconstructive surgery pelvic organ prolapse .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Women age 1881 year old schedule undergo major vaginal reconstructive surgery , include hysterectomy without hysterectomy Daily use steroid antiemetic agent Zofran , Reglan , Compazine Phenargan within one month surgery Regional anesthesia surgical procedure Chronic pain require opioid treatment daily History allergy study medication Severe renal liver disease Pregnancy Non English speak Psychiatric disorder preclude completion questionnaire Minor surgery involve overnight admission Surgery involve hysterectomy vaginal intraperitoneal apical suspension Hypersensitivity reaction steroid Evidence systemic fungal infection Evidence systemic infection Uncontrolled diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>pelvic organ prolapse surgery</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>postoperative nausea vomit</keyword>
	<keyword>peroperative administration</keyword>
</DOC>